$MSTX...found this on FDA site. MSTX received orphan drug designation.
Generic Name: Poloxamer 188 Trade Name: n/a Date Designated: 11-08-2013 Orphan Designation: Treatment of Acute Limb Ischemia Orphan Designation Status: Designated FDA Orphan Approval Status: Not FDA Approved for Orphan Indication Sponsor: Mast Therapeutics, Inc 12390 El Camino Real Suite 150 San Diego, CA 92130
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.